Cancer cell motility-inhibitory protein in the Dunning adenocarcinoma model.
Cell motility has been associated with metastatic ability in the Dunning R3327 rat prostatic adenocarcinoma model. Cancer cell motility promoters but not inhibitors have been described by many investigators. Serum-containing and serum-free media conditioned by the nonmotile, nonmetastatic G Dunning subline inhibited the motility of the highly motile, highly metastatic MAT-LyLu subline. Motility inhibition by the G subline-conditioned serum-free media was lost upon heating to 100 degrees C and by treatment with trypsin. The motility inhibitory protein(s) had a molecular weight exceeding 50,000 as determined by diafiltration. G subline-conditioned RPMI 1640 contained several proteins with molecular weights of between approximately 53,000 and 116,000 when analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. One of these bands may represent the first inhibitor of cancer cell motility identified.
Mohler
J L
JL
Department of Surgery, University of North Carolina, Chapel Hill 27599-7235.
Broskie
E N
EN
Ranparia
D J
DJ
Sharief
Y
Y
Coleman
W B
WB
Smith
G J
GJ
D000230:Adenocarcinoma / Q000737:chemistry*; D000818:Animals; D002465:Cell Movement; D004591:Electrophoresis, Polyacrylamide Gel; D008297:Male; D008970:Molecular Weight; D009363:Neoplasm Proteins / Q000737:chemistry / Q000302:isolation & purification*; D011471:Prostatic Neoplasms / Q000737:chemistry*; D051381:Rats; D014407:Tumor Cells, Cultured
D009363:Neoplasm Proteins